These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 26937432)
1. Visual assessment of biliary excretion of Gd-EOB-DTPA in patients with suspected diffuse liver disease - A biopsy-verified prospective study. Norén B; Dahlström N; Forsgren MF; Dahlqvist Leinhard O; Kechagias S; Almer S; Wirell S; Smedby Ö; Lundberg P Eur J Radiol Open; 2015; 2():19-25. PubMed ID: 26937432 [TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced MRI of the liver in Mrp2-deficient rats using the hepatobiliary contrast agent Gd-EOB-DTPA. Saito S; Obata A; Kashiwagi Y; Abe K; Murase K Invest Radiol; 2013 Jul; 48(7):548-53. PubMed ID: 23442774 [TBL] [Abstract][Full Text] [Related]
3. Separation of advanced from mild hepatic fibrosis by quantification of the hepatobiliary uptake of Gd-EOB-DTPA. Norén B; Forsgren MF; Dahlqvist Leinhard O; Dahlström N; Kihlberg J; Romu T; Kechagias S; Almer S; Smedby Ö; Lundberg P Eur Radiol; 2013 Jan; 23(1):174-81. PubMed ID: 22836161 [TBL] [Abstract][Full Text] [Related]
4. Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA. Ryeom HK; Kim SH; Kim JY; Kim HJ; Lee JM; Chang YM; Kim YS; Kang DS Korean J Radiol; 2004; 5(4):231-9. PubMed ID: 15637473 [TBL] [Abstract][Full Text] [Related]
5. Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis. Keller S; Sedlacik J; Schuler T; Buchert R; Avanesov M; Zenouzi R; Lohse AW; Kooijman H; Fiehler J; Schramm C; Yamamura J Eur Radiol; 2019 Feb; 29(2):818-828. PubMed ID: 30014204 [TBL] [Abstract][Full Text] [Related]
6. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats. Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739 [TBL] [Abstract][Full Text] [Related]
7. Gd-EOB-DTPA-enhanced-MR imaging in the inflammation stage of nonalcoholic steatohepatitis (NASH) in mice. Yamada T; Obata A; Kashiwagi Y; Rokugawa T; Matsushima S; Hamada T; Watabe H; Abe K Magn Reson Imaging; 2016 Jul; 34(6):724-729. PubMed ID: 26979540 [TBL] [Abstract][Full Text] [Related]
8. Assessment of liver function in primary biliary cirrhosis using Gd-EOB-DTPA-enhanced liver MRI. Nilsson H; Blomqvist L; Douglas L; Nordell A; Jonas E HPB (Oxford); 2010 Oct; 12(8):567-76. PubMed ID: 20887325 [TBL] [Abstract][Full Text] [Related]
9. Primovist, Eovist: what to expect? Van Beers BE; Pastor CM; Hussain HK J Hepatol; 2012 Aug; 57(2):421-9. PubMed ID: 22504332 [TBL] [Abstract][Full Text] [Related]
10. Dynamic-contrast-enhanced magnetic resonance imaging of cirrhotic liver parenchyma: A comparison between gadolinium-diethylenetriamine pentaacetic acid and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid. Lin CY; Chang WC; Chou CT; Chen RC J Chin Med Assoc; 2015 Nov; 78(11):666-72. PubMed ID: 26341453 [TBL] [Abstract][Full Text] [Related]
11. Effect of type 2 diabetes on Gd-EOB-DTPA uptake into liver parenchyma: replication study in human subjects. Kumasaka S; Seki Y; Kumasaka Y; Tsushima Y Abdom Radiol (NY); 2021 Oct; 46(10):4682-4688. PubMed ID: 34164726 [TBL] [Abstract][Full Text] [Related]
12. Potential of Gd-EOB-DTPA as an imaging biomarker for liver injury estimation after radiation therapy. Sun XL; Jiang X; Kuang Y; Xing L; Bu LY; Yuan SH; Yu JM; Zheng SS Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):354-359. PubMed ID: 31221569 [TBL] [Abstract][Full Text] [Related]
13. Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Gd-EOB-DTPA for the Evaluation of Liver Fibrosis Induced by Carbon Tetrachloride in Rats. Zhang W; Kong X; Wang ZJ; Luo S; Huang W; Zhang LJ PLoS One; 2015; 10(6):e0129621. PubMed ID: 26076199 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment. Gschwend S; Ebert W; Schultze-Mosgau M; Breuer J Invest Radiol; 2011 Sep; 46(9):556-66. PubMed ID: 21623212 [TBL] [Abstract][Full Text] [Related]
15. Assessment of liver function in thioacetamide-induced rat acute liver injury using an empirical mathematical model and dynamic contrast-enhanced MRI with Gd-EOB-DTPA. Saito S; Moriyama Y; Kobayashi S; Ogihara R; Koto D; Kitamura A; Matsushita T; Nishiura M; Murase K J Magn Reson Imaging; 2012 Dec; 36(6):1483-9. PubMed ID: 22711439 [TBL] [Abstract][Full Text] [Related]
16. Liver assessment using Gd-EOB-DTPA-enhanced magnetic resonance imaging in primary biliary cholangitis patients. Han D; Liu J; Jin E; He W Jpn J Radiol; 2019 May; 37(5):412-419. PubMed ID: 30798469 [TBL] [Abstract][Full Text] [Related]
17. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced MR finding of radiation-induced hepatic injury: relationship to absorbed dose and time course after irradiation. Okamoto D; Nishie A; Asayama Y; Tajima T; Ishigami K; Kakihara D; Nakayama T; Ohga S; Yoshitake T; Shioyama Y; Honda H Magn Reson Imaging; 2014 Jul; 32(6):660-4. PubMed ID: 24666574 [TBL] [Abstract][Full Text] [Related]
18. Measuring hepatic functional reserve using T1 mapping of Gd-EOB-DTPA enhanced 3T MR imaging: A preliminary study comparing with Nakagawa M; Namimoto T; Shimizu K; Morita K; Sakamoto F; Oda S; Nakaura T; Utsunomiya D; Shiraishi S; Yamashita Y Eur J Radiol; 2017 Jul; 92():116-123. PubMed ID: 28624009 [TBL] [Abstract][Full Text] [Related]
19. Liver fibrosis and Gd-EOB-DTPA-enhanced MRI: A histopathologic correlation. Verloh N; Utpatel K; Haimerl M; Zeman F; Fellner C; Fichtner-Feigl S; Teufel A; Stroszczynski C; Evert M; Wiggermann P Sci Rep; 2015 Oct; 5():15408. PubMed ID: 26478097 [TBL] [Abstract][Full Text] [Related]